Krause I, Cohen J, Blank M, Bakimer R, Cartman A, Hohmann A, Valesini G, Asherson R A, Khamashta M A, Hughes G R
Steinmet'z Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Lupus. 1992 Feb;1(2):91-6. doi: 10.1177/096120339200100206.
The frequency of two common idiotypes of anticardiolipin antibodies (aCL) was determined in sera from three groups of subjects, patients with systemic lupus erythematosus (SLE), with primary antiphospholipid syndrome (PAPS) and with monoclonal gammopathies (MG), as compared to normal population. The idiotype 1.10, which was derived from a patient with active SLE and antiphospholipid syndrome, was found more frequently among patients with PAPS (10.5%, 10.5% and 22.2% in MG, SLE and PAPS, respectively) than the idiotype H3, which was derived from a human hybridoma monoclonal aCL generated from a healthy subject immunized with tetanus and diphtheria. The latter idiotype was detected in 8.7%, 6.5% and 11.7% of patients with MG, SLE and PAPS, respectively. Incidental findings in this study include a high prevalence of aCL among patients with MG (23%) and a high prevalence of anti-dsDNA antibodies, detected only by a sensitive enzyme-linked immunosorbent assay, among patients with PAPS. Our results indicate that idiotypic diversity exists among aCL derived from different sources. Some of these cross-reactive idiotypes may be more pathogenic than others.
测定了三组受试者血清中两种常见抗心磷脂抗体(aCL)独特型的频率,这三组受试者分别为系统性红斑狼疮(SLE)患者、原发性抗磷脂综合征(PAPS)患者和单克隆丙种球蛋白病(MG)患者,并与正常人群进行了比较。源自一名患有活动性SLE和抗磷脂综合征患者的独特型1.10,在PAPS患者中出现的频率(在MG、SLE和PAPS患者中分别为10.5%、10.5%和22.2%)高于源自用破伤风和白喉免疫的健康受试者产生的人杂交瘤单克隆aCL的独特型H3。后一种独特型在MG、SLE和PAPS患者中的检测率分别为8.7%、6.5%和11.7%。本研究中的偶然发现包括MG患者中aCL的高患病率以及PAPS患者中仅通过灵敏的酶联免疫吸附测定检测到的抗双链DNA抗体的高患病率。我们的结果表明,源自不同来源的aCL之间存在独特型多样性。其中一些交叉反应性独特型可能比其他独特型更具致病性。